Showing results (191-200 of 635) with videos related to
Sort By:
Pageof 64
Biochemical Pharmacology|October 15, 1986
Hypophysectomy may non-selectively alter pharmacokinetic parameters to enhance the ability of haloperidol to increase striatal dopamine receptor density in the ratM D Simpson, P Jenner, C D MarsdenThe Journal of Pharmacy and Pharmacology|May 1, 1985
Properties of rat striatal D-2 dopamine receptors solubilized with the zwitterionic detergent CHAPSG J Kilpatrick, P Jenner, C D MarsdenJournal of Neural Transmission (Vienna, Austria : 1996)|November 6, 2023
Should continuous dopaminergic stimulation be a standard of care in advanced Parkinson's disease?Z Pirtošek, V Leta, P Jenner, et al.Neurology|December 1, 1992
New insights into the cause of Parkinson's diseaseP Jenner, A H Schapira, C D MarsdenMovement Disorders : Official Journal of the Movement Disorder Society|September 29, 2000
Endogenous dopaminergic tone and dopamine agonist actionS A Treseder, L A Smith, P JennerJournal of Neurochemistry|February 22, 2001
Effect of overexpression of wild-type and mutant Cu/Zn-superoxide dismutases on oxidative damage and antioxidant defences: relevance to Down's syndrome and familial amyotrophic lateral sclerosisM Lee, D Hyun, P Jenner, et al.Journal of Neurochemistry|February 22, 2001
Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insultM Lee, D Hyun, B Halliwell, et al.Biochemical Pharmacology|July 25, 1991
A redox reaction between MPP+ and MPDP+ to produce superoxide radicals does not impair mitochondrial functionM J Walker, P Jenner, C D MarsdenBiochemical Pharmacology|April 12, 1996
The isomers of thioctic acid alter C-deoxyglucose incorporation in rat basal gangliaT A Seaton, P Jenner, C D MarsdenBrain Research|June 12, 1992
Autoradiographic study of striatal D1 and D2 dopamine receptors in 6-OHDA-lesioned rats receiving foetal ventral mesencephalic grafts and chronic treatment with L-dopa and carbidopaS B Blunt, P Jenner, C D MarsdenPageof 64